Table 3b.
2005-2007 | 2010-2012 | |||||||
---|---|---|---|---|---|---|---|---|
% | 95% CI | Pairwise P value | Overall P value | % | 95% CI | Pairwise P value | Overall P value | |
Unadjusted Rates | ||||||||
All patients | 21.6 | (20.8-22.4) | <0.001 | 28.5 | (27.9-29.1) | <0.001 | ||
White | 22.4 | (21.5-23.3) | 29.2 | (28.5-29.9) | ||||
Black | 15.1 | (12.1-18) | <0.001 | 23.4 | (21.2-25.7) | <0.001 | ||
Hispanic | 16.2 | (13.4-19) | <0.001 | 23.6 | (20.9-26.3) | <0.001 | ||
Asian | 23.5 | (17.3-29.7) | 0.952 | 31.3 | (26.2-36.5) | 0.253 | ||
Adjusted Rates | ||||||||
Model 1 | 0.002 | <0.001 | ||||||
White | 21.4 | (18.3-24.6) | 29.0 | (26.2-31.8) | ||||
Black | 14.7 | (10.8-18.6) | <0.001 | 22.8 | (19.4-26.2) | <0.001 | ||
Hispanic | 20.3 | (16-24.6) | 0.509 | 24.2 | (20.4-27.9) | 0.002 | ||
Asian | 23.8 | (17-30.6) | 0.427 | 28.4 | (22.8-34) | 0.813 | ||
Model 2 | 0.021 | 0.001 | ||||||
White | 20.9 | (17.8-24.1) | 28.4 | (25.8-30.9) | ||||
Black | 15.4 | (11.4-19.5) | 0.002 | 23.7 | (20.4-26.9) | <0.001 | ||
Hispanic | 20.9 | (16.5-25.3) | 0.968 | 24.4 | (20.8-28) | 0.011 | ||
Asian | 22.3 | (15.8-28.9) | 0.633 | 27.0 | (21.7-32.3) | 0.578 | ||
Model 3 | 0.004 | <0.001 | ||||||
White | 21.7 | (18.7-24.8) | 27.9 | (25.3-30.4) | ||||
Black | 15.3 | (11.4-19.2) | <0.001 | 22.2 | (19.1-25.3) | <0.001 | ||
Hispanic | 21.4 | (17.1-25.8) | 0.865 | 24.1 | (20.6-27.6) | 0.022 | ||
Asian | 23.4 | (16.9-30) | 0.570 | 27.7 | (22.6-32.8) | 0.629 | ||
Model 4 | 0.006 | <0.001 | ||||||
White | 21.2 | (18.1-24.2) | 27.5 | (24.9-30.2) | ||||
Black | 15.1 | (11.2-19) | 0.001 | 21.6 | (18.4-24.8) | <0.001 | ||
Hispanic | 20.4 | (16.2-24.6) | 0.623 | 23.2 | (19.6-26.8) | 0.004 | ||
Asian | 23.4 | (16.8-30) | 0.450 | 26.3 | (21.1-31.6) | 0.620 | ||
Model 5 | 0.028 | 0.001 | ||||||
White | 20.9 | (18-23.8) | 27.4 | (24.9-29.8) | ||||
Black | 15.7 | (11.8-19.6) | 0.003 | 22.7 | (19.5-25.8) | <0.001 | ||
Hispanic | 21.2 | (17-25.5) | 0.861 | 24.6 | (21-28.2) | 0.064 | ||
Asian | 21.9 | (15.7-28.2) | 0.720 | 25.3 | (20.3-30.2) | 0.363 |
Note: Remission defined as the Clinical Disease Activity Index Score ≤2.8
Values are the mean with 95% confidence intervals.
Adjusted models included a series of five mixed model linear regression models including: practice setting (Model 1), patient demographic/socioeconomic factors (Model 2); markers of rheumatoid arthritis severity (Model 3), current rheumatoid arthritis severity treatment (Model 4) and all significant factors (p<0.05) from Models 1 through 4 (Model 5)